NasdaqGM - Nasdaq Real Time Price USD
Ardelyx, Inc. (ARDX)
At close: November 7 at 4:00 PM EST
After hours: 7:59 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-63,337.00
-89,717.00
-70,044.00
-152,551.00
-81,435.00
Investing Cash Flow
-6,265.00
-131,248.00
18,415.00
50,948.00
-31,442.00
Financing Cash Flow
83,264.00
146,295.00
75,341.00
82,999.00
22,776.00
End Cash Position
47,429.00
21,470.00
96,140.00
72,428.00
91,032.00
Income Tax Paid Supplemental Data
304.00
51.00
6.00
4.00
1.00
Interest Paid Supplemental Data
8,510.00
4,240.00
2,901.00
3,469.00
4,200.00
Capital Expenditure
-461.00
-344.00
-55.00
-1,867.00
-324.00
Issuance of Capital Stock
-12.00
119,236.00
71,625.00
101,146.00
21,047.00
Issuance of Debt
72,136.00
22,386.00
26,971.00
--
--
Repayment of Debt
--
--
-33,038.00
-19,444.00
-125.00
Free Cash Flow
-63,798.00
-90,061.00
-70,099.00
-154,418.00
-81,759.00
12/31/2020 - 6/19/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DAWN Day One Biopharmaceuticals, Inc.
15.76
+2.14%
TGTX TG Therapeutics, Inc.
27.90
+2.69%
IOVA Iovance Biotherapeutics, Inc.
12.28
+1.15%
MDGL Madrigal Pharmaceuticals, Inc.
354.85
+4.92%
APLS Apellis Pharmaceuticals, Inc.
28.74
-0.31%
VRNA Verona Pharma plc
38.18
+1.57%
LXRX Lexicon Pharmaceuticals, Inc.
1.3000
+7.44%
AVXL Anavex Life Sciences Corp.
7.64
-1.99%
BCRX BioCryst Pharmaceuticals, Inc.
7.67
-0.78%
TOVX Theriva Biologics, Inc.
2.1600
+9.64%